New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
07:32 EDTVVUS, ACRXAcelRx appoints Timothy Morris as CFO
AcelRx Pharmaceuticals (ACRX) announced the appointment of Timothy E. Morris as CFO. Morris brings 30 years of professional finance and accounting experience to AcelRx, 18 of those years spent in the role of CFO, most recently operating in this capacity at VIVUS (VVUS). Morris will be responsible for managing the company's finance operations, its information systems and human resource and investor relations functions. Jim Welch, who had served as CFO since October 2010, departed the company to pursue other business opportunities.
News For ACRX;VVUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 13, 2014
07:08 EDTACRXAcelRx to present positive efficacy results in Phase 3 trial of Zalviso
AcelRx Pharmaceuticals will present safety and efficacy data from a Phase 3 pivotal trial evaluating the Zalviso sufentanil sublingual tablet system for the treatment of moderate-to-severe acute pain following joint replacement surgery at the American Society of Regional Anesthesia and Pain Medicine 13th Annual Pain Medicine Meeting on November 13th to November 16th in San Francisco. Data from the sublingual sufentanil tablet system development program highlights efficacy across various demographic populations
November 11, 2014
10:20 EDTACRXHigh option volume stocks
High option volume stocks: RLGY TWC LITB SPM ACRX JWN OCR CALL CST ERIC
November 10, 2014
16:16 EDTACRXAcelRx sees FY14 R&D expenses $25M-$27M
Subscribe for More Information
16:15 EDTACRXAcelRx reports Q3 EPS (13c), consensus (22c)
Reports Q3 revenue $4.83M, consensus $4.43M.
07:12 EDTACRXAcelRx receives ISO certification of its quality management system
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use